Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Labussière

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 21, 2010
Radiosensitizing properties of bortezomib depend on therapeutic scheduleMarianne Labussière, Sophie Pinel, Marc Vandamme, et al.
Presse Medicale (Paris, France : 1983)|July 14, 2012
[Genetics and brain gliomas]Agusti Alentorn, Marianne Labussière, Marc Sanson, et al.
Biomed Research International|June 5, 2014
IDH1(R132H) mutation increases U87 glioma cell sensitivity to radiation therapy in hypoxiaXiao-Wei Wang, Marianne Labussière, Samuel Valable, et al.
Journal of Neuro-Oncology|November 19, 2013
Molecular analysis of diffuse intrinsic brainstem gliomas in adultsGerman Reyes-Botero, Marine Giry, Karima Mokhtari, et al.
Human Mutation|October 2, 2010
COLD PCR HRM: a highly sensitive detection method for IDH1 mutationsBlandine Boisselier, Yannick Marie, Marianne Labussière, et al.
Neurology|October 5, 2012
Detection of IDH1 mutation in the plasma of patients with gliomaBlandine Boisselier, Jaime Gállego Pérez-Larraya, Marta Rossetto, et al.
Anti-Cancer Drugs|October 2, 2008
Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenograftsMarianne Labussière, Alice Aarnink, Sophie Pinel, et al.
Biomed Research International|May 31, 2014
IDH mutations: genotype-phenotype correlation and prognostic impactXiao-Wei Wang, Pietro Ciccarino, Marta Rossetto, et al.
Journal of Neuro-Oncology|November 27, 2015
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomasUmberto Nencha, Amithys Rahimian, Marine Giry, et al.
Neuro-Oncology|October 18, 2012
Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomasAgustí Alentorn, Yannick Marie, Catherine Carpentier, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|December 21, 2010
Radiosensitizing properties of bortezomib depend on therapeutic scheduleMarianne Labussière, Sophie Pinel, Marc Vandamme, et al.
Presse Medicale (Paris, France : 1983)|July 14, 2012
[Genetics and brain gliomas]Agusti Alentorn, Marianne Labussière, Marc Sanson, et al.
Biomed Research International|June 5, 2014
IDH1(R132H) mutation increases U87 glioma cell sensitivity to radiation therapy in hypoxiaXiao-Wei Wang, Marianne Labussière, Samuel Valable, et al.
Journal of Neuro-Oncology|November 19, 2013
Molecular analysis of diffuse intrinsic brainstem gliomas in adultsGerman Reyes-Botero, Marine Giry, Karima Mokhtari, et al.
Human Mutation|October 2, 2010
COLD PCR HRM: a highly sensitive detection method for IDH1 mutationsBlandine Boisselier, Yannick Marie, Marianne Labussière, et al.
Neurology|October 5, 2012
Detection of IDH1 mutation in the plasma of patients with gliomaBlandine Boisselier, Jaime Gállego Pérez-Larraya, Marta Rossetto, et al.
Anti-Cancer Drugs|October 2, 2008
Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenograftsMarianne Labussière, Alice Aarnink, Sophie Pinel, et al.
Biomed Research International|May 31, 2014
IDH mutations: genotype-phenotype correlation and prognostic impactXiao-Wei Wang, Pietro Ciccarino, Marta Rossetto, et al.
Journal of Neuro-Oncology|November 27, 2015
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomasUmberto Nencha, Amithys Rahimian, Marine Giry, et al.
Neuro-Oncology|October 18, 2012
Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomasAgustí Alentorn, Yannick Marie, Catherine Carpentier, et al.
Pageof 3